Changes in motor activity and forebrain [propionyl-3H]propionylated-CCK-8 binding in mice after repeated administration of drugs affecting cholecystokinin receptors.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  European Journal of Pharmacology

• Publication date

  1991-09-24

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-2999(91)90283-VPMID 1748160
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouse

  2005cited by this paper
• The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat.

  1990cited by this paper
• Facilitatory effects of CCK-8 in the dorsomedial nucleus accumbens on apomorphine-induced jaw movements in rats

  1990cited by this paper
• Pharmacological and mechanistic studies of cholecystokinin-facilitated [3H]dopamine efflux from rat nucleus accumbens.

  1989cited by this paper
• Ceruletide suppresses endogenous dopamine release via vagal afferent system, studied by in vivo intracerebral dialysis.

  1989cited by this paper
• Microinjection of cholecystokinin into the rat ventral tegmental area potentiates dopamine‐induced hypolocomotion

  1989cited by this paper
• Type-A cholecystokinin binding sites in cow brain: characterization using (-)-[3H]L364718 membrane binding assays.

  1989cited by this paper
• Morphine-induced analgesia in the rat paw pressure test is blocked by CCK and enhanced by the CCK antagonist MK-329.

  1989cited by this paper
• Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokinin.

  1989cited by this paper
• The effects of cholecystokinin (CCK-8) on dopamine-containing nerve terminals in the caudate nucleus and nucleus accumbens of the anesthetized rat: an in vivo electrochemical study.

  1989cited by this paper
• Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718.

  1988cited by this paper
• Potency of L-364,718 as an antagonist of the behavioral effects of peripherally administered cholecystokinin.

  1988cited by this paper
• [Species differences in the behavioral effects of cerulein--an agonist of the receptors of the octapeptide cholecystokinin--in white mice and rats].

  1988cited by this paper
• Classification and function of CCK receptors

  1987cited by this paper
• Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists

  1987cited by this paper
• Differential effects of proglumide on mesolimbic and nigrostriatal dopamine function

  1987cited by this paper
• Population response of midbrain dopaminergic neurons to neuroleptics: further studies on time course and nondopaminergic neuronal influences

  1987cited by this paper
• Two brain cholecystokinin receptors: implications for behavioral actions.

  1986cited by this paper
• Cholecystokinin-dopamine coexistence: electrophysiological actions corresponding to cholecystokinin receptor subtype

  1986cited by this paper
• beta-Endorphin involvement in the antidopaminergic effect of caerulein.

  1986cited by this paper
• Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence

  1985cited by this paper
• Neuropharmacological Profile of Cholecystokinin‐like Peptides

  1985cited by this paper
• The continuity of dopamine receptor antagonism can dictate the long-term behavioural consequences of a mesolimbic infusion of dopamine.

  1985cited by this paper
• Dopamine receptor elevation by cholecystokinin.

  1984cited by this paper
• Caerulein, a cholecystokinin-related peptide, depresses somatic function via the vagal afferent system.

  1983cited by this paper
• Nucleus tractus solitarius lesions block the behavioral actions of cholecystokinin.

  1983cited by this paper
• Motor inhibition induced by aporphine derivatives in the mouse

  1983cited by this paper
• Characterization of Cholecystokinin Binding Sites in Rat Cerebral Cortex Using a 125I‐CCK‐8 Probe Resistant to Degradation

  1983cited by this paper
• A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing.

  1980cited by this paper

• Ceruletide, an analog of cholecystokinin octapeptide: New perspectives on its efficacy

  2006cites this paper
• Evidence for the contribution of CCKB receptor mechanisms to individual differences in amphetamine-induced locomotion.

  1994cites this paper
• Evidence for potentiation by CCK antagonists of the effect of cholecystokinin octapeptide in the elevated plus-maze.

  1994cites this paper
• Anti-exploratory effect of N-methyl-D-aspartate in elevated plus-maze. Involvement of NMDA and CCK receptors.

  1993cites this paper
• Effects of diurnal phase and pimozide on cholecystokinin-elicited hypoactivity in the hamster.

  1992cites this paper